Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.
Saved in:
| Title: | Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments. |
|---|---|
| Authors: | Steinhoff M; Department of Dermatology, UCD Charles Institute of Dermatology, University College Dublin, Dublin, Ireland. martin.steinhoff@ucd.ie.; Department of Dermatology, University of California, San Diego, CA, USA. martin.steinhoff@ucd.ie.; Department of Neurosciences, University of California, Davis, CA, USA. martin.steinhoff@ucd.ie., Vocanson M; CIRI, International Center for Infectiology Research, Université de Lyon, Lyon, France.; Inserm, U1111, Lyon, France., Voegel JJ; Galderma International S.A.S., Paris, France., Hacini-Rachinel F; Galderma International S.A.S., Paris, France., Schäfer G; Galderma International S.A.S., Paris, France. |
| Source: | Advances in therapy [Adv Ther] 2016 Sep; Vol. 33 (9), pp. 1481-501. Date of Electronic Publication: 2016 Jul 18. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
| ISSN: | 1865-8652 |
|---|---|
| DOI: | 10.1007/s12325-016-0380-z |
